Found 5 matching trials
A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
PHASE1* To evaluate the safety and tolerability of ERAS-007 monotherapy administe...
Status
Active Not Recruiting
Location
Sarah Cannon Research Institute (HealthONE)
A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors
PHASE1* To evaluate the safety and tolerability of escalating doses of ERAS-601 w...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
A Study of ERAS-601 in People With Chordoma
PHASE1The researchers are doing this study is to find out whether ERAS-601 is a s...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC
PHASE1* To evaluate the safety and tolerability of escalating doses of ERAS-007 o...
A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Hematologic Malignancies
PHASE1* To evaluate the safety and tolerability of escalating doses of ERAS-007 o...
Location
University of California San Francisco